Related content

Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study

By Biglia Nicoletta   Peano Elisa   Sgandurra Paola   Moggio Giulia   Panuccio Enrico   Migliardi Marco   Ravarino Nicoletta   Ponzone Riccardo   Sismondi Piero  

Gynecological Endocrinology, Vol. 26, Iss. 6, 2010-06 ,pp. : 404-412

Informa Healthcare

Access to resources Recommend Favorite

Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients

By Pup Lino Del  

Gynecological Endocrinology, Vol. 28, Iss. 9, 2012-09 ,pp. : 740-745

Informa Healthcare

Access to resources Recommend Favorite

High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy

By Labrie Fernand   Archer David   Bouchard Céline   Fortier Michel   Cusan Leonello   Gomez José-luis   Girard Ginette   Baron Mira   Ayotte Normand   Moreau Michèle   Dubé Robert   Côté Isabelle   Labrie Claude   Lavoie Lyne   Berger Louise   Martel Céline   Balser John  

Gynecological Endocrinology, Vol. 26, Iss. 7, 2010-07 ,pp. : 524-532

Informa Healthcare

Access to resources Recommend Favorite

Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause

By Repse-fokter Alenka   Takac Iztok   Fokter Samo  

Gynecological Endocrinology, Vol. 24, Iss. 7, 2008-01 ,pp. : 399-404

Informa Healthcare

Access to resources Recommend Favorite

Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy

By Milewicz A.   Szymański W.   Rużyłło W.   Zgliczyński S.   Reinfus M.   Zieliński J.   Debski R.   Demissie M.   Tworowska U.  

Gynecological Endocrinology, Vol. 16, Iss. 5, 2002-10 ,pp. : 385-389

Informa Healthcare

Access to resources Recommend Favorite